ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

NCI Awards 41.5 Million for DES Study

February 28, 1975

December Business & Regulatory Report included in this issue.

December 12, 2003

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

May 4, 2001